Immune Memory Could Be Behind Recurring Arthritis While Patients Undergo Cancer Immunotherapy


Date:

(MENAFN- Investor Brand Network) immunotherapy against cancer. In many of these cases, the inflammation recurs, and the treatment impacts the quality of life of the affected patients. Scientists have been trying to understand why this type of adverse event happens, and a new study sheds some light on the issue.

A lot is still being discovered about why immunotherapy works for some patients and not others, and why some patients respond differently while undergoing this treatment. We can therefore expect more insights on this relatively new approach to treating cancer as enterprises like Calidi Biotherapeutics Inc. (NYSE American: CLDI) proceed with...

Read More>>

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 75+ brands within the Dynamic Brand Portfolio IBN: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries ; (2) article and editorial syndication to 5,000+ outlets ; (3) enhanced press release enhancement to ensure maximum impact ; (4) social media distribution via IBN to millions of social media followers ; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today's market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

MENAFN19112026000224011066ID1111992027


Investor Brand Network

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.



More Story

Search